Background: Hepatocellular carcinoma (HCC) (about 85–90% of primary liver cancer) is
particularly prevalent in China because of the high prevalence of chronic hepatitis B infection. …

Objective There is little evidence that adjuvant therapy after radical surgical resection of
hepatocellular carcinoma (HCC) improves recurrence-free survival (RFS) or overall survival (OS)…

Aim The prognostic value of the newly raised objective liver function assessment tool, the
albumin–bilirubin (ALBI) grade, in patients with hepatocellular carcinoma has not been fully …

The low resection and high recurrence rates in hepatocellular carcinoma (HCC) are the major
challenges to improving prognosis. Neoadjuvant and conversion therapies are underlying …

Conflicting results about the prognostic value of Glasgow Prognostic Score (GPS) in
hepatocellular carcinoma (HCC) patients have been reported. We searched the available articles …

AIM: To investigate the expression of key biomarkers in hepatoma cell lines, tumor cells from
patients’ blood samples, and tumor tissues. METHODS: We performed the biomarker tests …

Background Conflicting results about the prognostic value of surgical margin status in patients
with intrahepatic cholangiocarcinoma (ICC) have been reported. We aimed to assess the …

AIM: To present the experience and outcomes of the surgical treatment for the patients with
anorectal melanoma from the Cancer Hospital, Chinese Academy of Medical Sciences. …

Background Gastrectomy was reported to be an excessive approach for early gastric cancer
with signet ring cell carcinoma. This study was conducted to explore the feasibility of …

Background Little is known about the prognosis of intrahepatic cholangiocarcinoma (ICC)
patients with hepatitis B virus (HBV) infection following surgical resection. Methods The clinico‐…